Further studies must be carried out to understand if the inhibition of nNOS, by an excessive NADPH oxidase free radical overproduction, could constitute a cytoprotective mechanism against the negative consequences of the continual enhancement of oxidative molecules, which provides a novel clue to extend the physiological and pathophysiological roles of oxidative stress in the fragile X syndrome. The gene discussed is FMO5; the disease is fragile X syndrome.